热门资讯> 正文
Plus Therapeutics获准180天恢复与纳斯达克合规
2025-11-17 21:06
- Plus Therapeutics (PSTV) announced on Monday that it has received an additional 180-day extension period from the Nasdaq to regain compliance with the $1.00 minimum bid price requirement as per Nasdaq Listing Rule 5550(a)(2).
- The company has until May 11, 2026, to meet the minimum bid price requirement.
- If at any time during the additional 180-day extension, the closing bid price of the common stock is at least $1.00 per share for a minimum of 10 consecutive business days, the Nasdaq will provide the company with a written confirmation of compliance.
More on Plus Therapeutics
- Plus Therapeutics rises on the back of UnitedHealthcare coverage deal
- Plus Therapeutics receives $1.9M CPRIT payment for cancer program
- Seeking Alpha’s Quant Rating on Plus Therapeutics
- Historical earnings data for Plus Therapeutics
- Financial information for Plus Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
